Vanguard Rapid Resp 3 Intranasal

Company: Zoetis

Canine Adenovirus Type 2-Parainfluenza-Bordetella Bronchiseptica Vaccine

MODIFIED LIVE VIRUS & AVIRULENT LIVE CULTURE

BORDETELLA

8+ WEEKS

NASAL

To Reconstitute:

Rehydrate the vaccine with the sterile diluent for vaccination.

FOR EASIER STORAGE & VIEWING

● Pull down on the tab.

● Flip tab out and set bottom tray of vials inside top lid.

This product has been shown to be effective for the vaccination of healthy dogs 8 weeks of age or older against canine adenovirus type 2 (CAV2), canine parainfluenza virus (CPIV), and B. bronchiseptica. A duration of immunity of at least one year has been demonstrated against CAV2, CPIV, and B. bronchiseptica. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Directions For Use

Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided and shake well. Draw contents back into the syringe, remove the needle and administer a single 0.5-mL dose intranasally. Historically, annual revaccination with this product was recommended. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian or the manufacturer is recommended.

Precautions

Store at 2°-8°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Sterilized syringes should be used to administer this vaccine. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine. Inactivate unused contents before disposal. This product has not been tested in pregnant animals. In case of anaphylactoid reaction, administer epinephrine. Do not mix with other products, except as specified above. In case of human exposure, contact a physician.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471.

VLN 190/PCN 12X1.21

Zoetis Inc., Kalamazoo, MI 49007, USA

CPN: 3690524.2